These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 28579611)

  • 1. Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need.
    Field MC; Horn D; Fairlamb AH; Ferguson MAJ; Gray DW; Read KD; De Rycker M; Torrie LS; Wyatt PG; Wyllie S; Gilbert IH
    Nat Rev Microbiol; 2017 Jul; 15(7):447. PubMed ID: 28579611
    [No Abstract]   [Full Text] [Related]  

  • 2. Author Correction: Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need.
    Field MC; Horn D; Fairlamb AH; Ferguson MAJ; Gray DW; Read KD; De Rycker M; Torrie LS; Wyatt PG; Wyllie S; Gilbert IH
    Nat Rev Microbiol; 2018 Nov; 16(11):714. PubMed ID: 30206344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Picking pockets to fuel antimicrobial drug discovery.
    Hunter WN
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):980-4. PubMed ID: 17956259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Author Correction: Anti-trypanosomatid drug discovery: progress and challenges.
    De Rycker M; Wyllie S; Horn D; Read KD; Gilbert IH
    Nat Rev Microbiol; 2022 Nov; 20(11):702. PubMed ID: 36100771
    [No Abstract]   [Full Text] [Related]  

  • 5. Did trypanosomatid parasites contain a eukaryotic alga-derived plastid in their evolutionary past?
    Bodył A; Mackiewicz P; Milanowski R
    J Parasitol; 2010 Apr; 96(2):465-75. PubMed ID: 20540605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foreword. Trypanosomatid disease drug discovery and target identification.
    N Setzer W
    Future Med Chem; 2013 Oct; 5(15):1703-4. PubMed ID: 24144406
    [No Abstract]   [Full Text] [Related]  

  • 7. Advances in the role of microRNAs in lipid metabolism-related anti-atherosclerotic drug discovery.
    Wang L; Yang Y; Hong B
    Expert Opin Drug Discov; 2013 Aug; 8(8):977-90. PubMed ID: 23668290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragment-based approaches to anti-HIV drug discovery: state of the art and future opportunities.
    Huang B; Kang D; Zhan P; Liu X
    Expert Opin Drug Discov; 2015 Dec; 10(12):1271-81. PubMed ID: 26372893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collaborative actions in anti-trypanosomatid chemotherapy with partners from disease endemic areas.
    Dujardin JC; González-Pacanowska D; Croft SL; Olesen OF; Späth GF
    Trends Parasitol; 2010 Aug; 26(8):395-403. PubMed ID: 20538522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection rates and pathogenicity of trypanosomatid gut parasites in the water strider Gerris odontogaster (Zett.) (Heteroptera: Gerridae).
    Arnqvist G; Mäki M
    Oecologia; 1990 Sep; 84(2):194-198. PubMed ID: 28312752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The trypanothione system and its implications in the therapy of trypanosomatid diseases.
    Flohé L
    Int J Med Microbiol; 2012 Oct; 302(4-5):216-20. PubMed ID: 22889611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of lean manufacturing concepts to drug discovery: rapid analogue library synthesis.
    Weller HN; Nirschl DS; Petrillo EW; Poss MA; Andres CJ; Cavallaro CL; Echols MM; Grant-Young KA; Houston JG; Miller AV; Swann RT
    J Comb Chem; 2006; 8(5):664-9. PubMed ID: 16961404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and barcoding by analysis of spliced leader RNA gene sequences of new isolates of Trypanosomatidae from Heteroptera in Costa Rica and Ecuador.
    Maslov DA; Westenberger SJ; Xu X; Campbell DA; Sturm NR
    J Eukaryot Microbiol; 2007; 54(1):57-65. PubMed ID: 17300521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Trypanosoma cruzi activity of nicotinamide.
    Soares MB; Silva CV; Bastos TM; Guimarães ET; Figueira CP; Smirlis D; Azevedo WF
    Acta Trop; 2012 May; 122(2):224-9. PubMed ID: 22281243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial compound libraries for drug discovery: an ongoing challenge.
    Geysen HM; Schoenen F; Wagner D; Wagner R
    Nat Rev Drug Discov; 2003 Mar; 2(3):222-30. PubMed ID: 12612648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cAMP signalling in trypanosomatids: role in pathogenesis and as a drug target.
    Makin L; Gluenz E
    Trends Parasitol; 2015 Aug; 31(8):373-9. PubMed ID: 26004537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pharmacological agents, sleep deprivation, hypoxia and transcranial magnetic stimulation on electroencephalographic rhythms in rodents: towards translational challenge models for drug discovery in Alzheimer's disease.
    Babiloni C; Infarinato F; Aujard F; Bastlund JF; Bentivoglio M; Bertini G; Del Percio C; Fabene PF; Forloni G; Herrero Ezquerro MT; Noè FM; Pifferi F; Ros-Bernal F; Christensen DZ; Dix S; Richardson JC; Lamberty Y; Drinkenburg W; Rossini PM
    Clin Neurophysiol; 2013 Mar; 124(3):437-51. PubMed ID: 23040292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of high-throughput ADME in drug discovery.
    Kassel DB
    Curr Opin Chem Biol; 2004 Jun; 8(3):339-45. PubMed ID: 15183334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond the hundred dollar genome--drug discovery futures.
    Selwood DL
    Chem Biol Drug Des; 2013 Jan; 81(1):1-4. PubMed ID: 23253126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Trifluoromethylquinoxaline N,N'-dioxides as anti-trypanosomatid agents. Identification of optimal anti-T. cruzi agents and mechanism of action studies.
    Benitez D; Cabrera M; Hernández P; Boiani L; Lavaggi ML; Di Maio R; Yaluff G; Serna E; Torres S; Ferreira ME; Vera de Bilbao N; Torres E; Pérez-Silanes S; Solano B; Moreno E; Aldana I; López de Ceráin A; Cerecetto H; González M; Monge A
    J Med Chem; 2011 May; 54(10):3624-36. PubMed ID: 21506600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.